AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paetau, I.
Right arrow Articles by Clevidence, B. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paetau, I.
Right arrow Articles by Clevidence, B. A
Agricola
Right arrow Articles by Paetau, I.
Right arrow Articles by Clevidence, B. A
American Journal of Clinical Nutrition, Vol. 70, No. 4, 490-494, October 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements1,2,3,4

Inke Paetau, David Rao, Eugene R Wiley, Ellen D Brown and Beverly A Clevidence

1 From the US Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Phytonutrients Laboratory, Beltsville, MD.

Background: Lycopene has been identified as a phytochemical with potentially protective health benefits.

Objective: Our objective was to monitor lycopene changes in buccal mucosa cells (BMCs) in response to 3 vehicles for oral delivery of lycopene.

Design: Fifteen healthy subjects ingested lycopene-rich tomato juice, tomato oleoresin, lycopene beadlets (each containing 70–75 mg lycopene) and a placebo for 4 wk each in a randomized crossover design while consuming self-selected diets. A 6-wk washout period separated the treatment periods. BMCs were collected at baseline and after 4 wk of supplementation.

Results: Lycopene in BMCs increased significantly ({approx}2-fold) after 4 wk of ingestion of oleoresin and of beadlets to 4.95 (P < 0.001) and 3.75 µg/g protein (P = 0.053), respectively, but was not significantly affected by tomato juice treatment. The placebo treatment produced a significant decrease in BMC lycopene concentrations (P = 0.018). We observed significant treatment differences between oleoresin and tomato juice, oleoresin and placebo, and beadlets and placebo. BMC concentrations of phytofluene and ß-carotene, which were present in small amounts in the lycopene-containing treatments, increased significantly with ingestion of these products. Strong correlations were found between plasma and BMC concentrations of lutein, ß-cryptoxanthin, {alpha}-carotene, and ß-carotene. In contrast, correlations between lycopene concentrations in plasma and in BMCs were weak and not significant for any treatment.

Conclusions: The cellular content of lycopene and other tomato-related carotenoids with proposed beneficial health effects can be increased through prolonged supplementation.

Key Words: Lycopene • phytofluene • carotenoids • buccal cells • plasma • tomato juice • oleoresin • beadlets • humans




This article has been cited by other articles:


Home page
J. Nutr.Home page
A. R. Kristal and J. M. Schenk
Directions for Future Epidemiological Research in Lycopene and Prostate Cancer Risk
J. Nutr., August 1, 2005; 135(8): 2037S - 2039S.
[Full Text] [PDF]


Home page
J. Nutr.Home page
M. Richelle, K. Bortlik, S. Liardet, C. Hager, P. Lambelet, M. Baur, L. A. Applegate, and E. A. Offord
A Food-Based Formulation Provides Lycopene with the Same Bioavailability to Humans as That from Tomato Paste
J. Nutr., March 1, 2002; 132(3): 404 - 408.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition